ABUS
Arbutus Biopharma Corporation
$4.43
+$0.18(+4.24%)
30
Overall
--
Value
30
Tech
--
Quality
Market Cap
$843.47M
Volume
1.17M
52W Range
$2.71 - $5.10
Target Price
$5.25
EPS Estimates Overview
| Current Quarter | $-0.02 | Next Quarter | $-0.02 |
| Current Year | $-0.19 | Next Year | $-0.17 |
| QoQ Growth | +0.0% | YoY Growth | +10.5% |
| 3Y EPS CAGR | +22.9% | Target Price | $5.25 |
| Consensus | Buy | Upside | +18.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABUS | $4.43 | +4.2% | 1.17M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Arbutus Biopharma Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW